Cargando…
Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial
INTRODUCTION: The clinical characteristics of autoantibody-mediated autoimmune diseases are diverse. Yet, medical treatment and the associated complications are similar, that is, the occurrence of long-term side effects and the problem that a significant proportion of patients are non-responders. Th...
Autores principales: | Kohler, Siegfried, Märschenz, Stefanie, Grittner, Ulrike, Alexander, Tobias, Hiepe, Falk, Meisel, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352837/ https://www.ncbi.nlm.nih.gov/pubmed/30696682 http://dx.doi.org/10.1136/bmjopen-2018-024523 |
Ejemplares similares
-
Protocol of the randomised placebo controlled pilot trial of the management of acute sciatica (SCIATICA): a feasibility study
por: Lassere, Marissa Nichole, et al.
Publicado: (2018) -
Bortezomib at therapeutic doses poorly passes the blood–brain barrier and does not impair cognition
por: Huehnchen, Petra, et al.
Publicado: (2020) -
OASIS—a randomised, placebo-controlled trial of oral glucocorticoids for leg pain in patients with acute sciatica: trial protocol
por: Liu, Chang, et al.
Publicado: (2020) -
Efficacy and safety of a supplement combination for hand osteoarthritis pain: protocol for an internet-based randomised placebo-controlled trial (The RADIANT study)
por: Liu, Xiaoqian, et al.
Publicado: (2020) -
Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol
por: Calderone, Alicia, et al.
Publicado: (2016)